Adel Rafai Far
12Patents
2h-index
20Co-inventors
50Inventor score
Filing activity: Aug 11, 2006 → Jun 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9295687B1 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Performing Operations; Transporting | 3 | Active |
| US9439921B2 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Performing Operations; Transporting | 2 | Active |
| US8524691B2 | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections | Human Necessities | 2 | Active |
| US9700575B2 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Performing Operations; Transporting | 1 | Active |
| US10039780B2 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Performing Operations; Transporting | 1 | Active |
| US8404664B2 | Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections | Human Necessities | 0 | Active |
| US8946144B2 | Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections | Human Necessities | 0 | Active |
| US10864249B2 | High purity oritavancin and method of producing same | Chemistry; Metallurgy | 0 | Active |
| US8901072B2 | Glycopeptide and lipoglycopeptide antibiotics with improved solubility | Human Necessities | 0 | Active |
| US10201587B2 | Methods of inhibiting and treating biofilms using glycopeptide antibiotics | Human Necessities | 0 | Active |
| US10328118B2 | High purity oritavancin and method of producing same | Chemistry; Metallurgy | 0 | Active |
| US9649352B2 | High purity oritavancin and method of producing same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.